Erschienen in:
18.10.2018 | Clinical Mycology Lab Issues (S Córdoba, Section Editor)
Emergence of Resistance to Fluconazole in Candida albicans Isolated From Vaginal Discharge
verfasst von:
Susana Córdoba, Constanza Taverna, Walter Vivot, Wanda Szusz, Matias Vivot, Guillermina Isla, Graciela Davel
Erschienen in:
Current Fungal Infection Reports
|
Ausgabe 4/2018
Einloggen, um Zugang zu erhalten
Abstract
Purpose of Review
To provide information about the emergence of fluconazole resistance in Candida albicans isolated from vaginal discharge, in a global context, and to update the in vitro susceptibility profile of this species from Argentina.
Recent Findings
Vulvovaginal candidiasis is the second most common vaginal infection after vaginal bacteriosis. C. albicans remains the prevalent etiological yeast species, and despite antifungal treatment, the rate of recurrence remains high, which may be associated to antifungal resistance.
Summary
Data here presented were obtained from the study of C. albicans strains isolated from patients with clinical signs of vulvovaginal candidiasis from 1996 to 2017. Data obtained could represent the susceptibility profile of C. albicans strains circulating in Argentina and could be of potential usefulness to monitor and guide therapy, and also suggests the need for greater surveillance programs to detect fluconazole resistance over time.